英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Devested查看 Devested 在百度字典中的解释百度英翻中〔查看〕
Devested查看 Devested 在Google字典中的解释Google英翻中〔查看〕
Devested查看 Devested 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Nonstatin Cholesterol Medications - NEXLIZET® NEXLETOL®
    NEXLIZET is a combination of 2 medicines, bempedoic acid and ezetimibe The bempedoic acid portion of NEXLIZET was studied in a large clinical trial on reducing cardiovascular death, heart attack, stroke, heart stent or bypass surgery in people with statin intolerance
  • Nexlizet: Uses, Dosage, Side Effects, Warnings - Drugs. com
    What is the cost of Nexlizet? The cost of prescription drugs varies depending on your insurance plan and which pharmacy you use Refer to our Nexlizet price guide page for more information about Nexlizet cost You may also be eligible for a Nexlizet copay card or Nexlizet coupon through the NEXSTEP Patient Support Program This program provides information about why you have been prescribed
  • PATIENT INFORMATION NEXLIZET (NEX-lee-zet) (bempedoic acid . . .
    Bempedoic acid, a component of NEXLIZET, is used: to lower the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, or heart procedures like stent placement or bypass surgery in adults at increased risk for these events who are unable to take recommended statin treatment (a cholesterol-lowering medicine), or are not taking a statin
  • Nexlizet (bempedoic acid ezetimibe): Uses, Side . . . - WebMD
    Find patient medical information for Nexlizet (bempedoic acid ezetimibe) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
  • label - Food and Drug Administration
    INDICATIONS AND USAGE NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated: • As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C) lowering therapies, to reduce LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH)
  • NEXLIZET® NEXLETOL® HCP Information - Official Site
    Discover NEXLIZET® and NEXLETOL®, approved to lower LDL-C and the risk of MI and coronary revascularization See ISI and full prescribing information
  • Bempedoic acid and ezetimibe (oral route) - Side effects . . .
    Bempedoic acid and ezetimibe combination is also used to lower the risk of heart attack and heart procedures (eg, stent placement or bypass surgery) in patients who are unable to take or are not taking a cholesterol-lowering medicine (eg, statin), who have heart disease or who are at high risk for heart disease
  • Bempedoic Acid (NEXLETOL) and Bempedoic Acid Ezetimibe (NEXLIZET)
    Finally, if a patient is completely intolerant of statin therapy (i e , no statin can be used) and ezetimibe has not or is not expected to provide clinically desired LDL-C reduction from untreated baseline or achieve LDL-C goal (consistent with established guidelines), use of a monoclonal antibody inhibitors of PCSK9 is preferred to bempedoic acid because of the differences in magnitude of
  • Nexlizet: Uses, Prices, Dosage, Side Effects More - Inside Rx
    Discover more about Nexlizet, including its uses, side effects, dosage, images, and alternative medications Nexlizet prices starting at $397 84
  • Nexlizet Medicare Coverage and Co-Pay Details - GoodRx
    Nexlizet is a brand-name combination medication that treats adults with high cholesterol, including those with a genetic condition called familial hypercholesterolemia For adults at risk for heart disease who aren't taking statins, Nexlizet can help lower the risk of heart attack and the need for a procedure to open blocked arteries to help blood flow to the heart (e g , stent placement





中文字典-英文字典  2005-2009